Company: ABBV
Filing Date: 2025-03-10
Form Type: PRE 14A
Source: 0001558370-25-002603
Chunk: 4

Company: AbbVie Inc.
Filing Date: 2025-03-10
Form: PRE 14A
Chunk 4
---
� We do not have a stockholder rights plan or “poison pill”✓ Our directors are elected by a majority vote of our stockholders for uncontested elections, and we have a resignation policy if the director fails to receive a majority of the votes cast                                                                                                                                                                                                                                 | ​ | Board and executive accountability✓ Annual executive succession planning ✓ Minimum stock ownership guidelines are in place for the CEO and other NEOs✓ We have a related person transaction policy to ensure appropriate oversight✓ We hold an annual say-on-pay advisory vote on executive compensation                                                         |
| ​                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | ​ | ​                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | ​ | ​                                                                                                                                                                                                                                                                                                                                                                |
| ​                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | ​ | ​                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | ​ | ​                                                                                                                                                                                                                                                                                                                                                                |
| Board composition and effectiveness✓ Our governance guidelines restrict the number of boards our directors may serve on to prevent overboarding✓ Annual board and committee self-assessments and annual board succession planning, including an assessment of current director skillset, upcoming potential retirements, diversity of the board, and optimal board size✓ For inclusion on the Board, the nominations and governance committee considers a range of factors, including skillset, experience, and reputation | ​ | Clawback and anti-hedging and anti-pledging policies✓ Mandatory clawback of excess compensation in the event of a restatement, plus broad discretion to clawback compensation in the event of a material breach of the AbbVie Code of Business Conduct ✓ Directors and executive officers are prohibited from buying or selling any financial instruments designed to hedge or offset any decrease in the market value of AbbVie equity securities they hold✓ Directors and executive officers are prohibited from pledging AbbVie stock as collateral for a loan | ​ | Other ESG practices✓ ESG goals are incorporated into our executive compensation programs for all executives✓ We are guided by strong ethics programs and supplier guidelines✓ We disclose our corporate political contributions, our trade association memberships, and oversight process on our website and expanded these disclosures in 2022, 2023, and 2024​ |

6 | 2025 Proxy Statement

| ​ | ​             |
| ​ | PROXY SUMMARY |

Our ESG Highlights As a research-driven global biopharmaceutical company, we apply the same high standards and rigor to the medicines and solutions we pursue, to how we operate our business. We recognize that our company and our industry have a unique opportunity to make a real difference in people’s lives